Article
Genotyping of CYP2C19 polymorphisms and its clinical validation in the ethnic Arab population.
The Journal of pharmacy and pharmacology - 1 Jul 2015
Tayeb Hamsa T, Bakheet Dana H, Zaza Khaled, Wakil Salma M, Dzimiri Nduna
Abstract excerpt
OBJECTIVES: The drug-metabolizing enzymes and transporters (DMET) Plus microarray and x-Tag assays have recently been developed for genotyping individuals in personalized medicine. Furthermore, the cytochrome 450-2C19 (CYP2C19) is a key metabolic enzyme encoded by a polymorphic gene commonly associated with diminished metabolism and variable clinical responses to several drugs in an ethnicity-dependent fashion....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
